查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405849

IVD（體外診斷）用酶的市場規模、佔有率和趨勢分析報告：按酶類型、疾病類型、技術類型、最終用途、地區和細分市場預測，2023-2030 年

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 199 Pages | 商品交期: 2-10個工作天內

價格

IVD（體外診斷）酵素市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2023年至2030年全球IVD（體外診斷）酵素市場規模將以7.9%的複合年成長率成長，2030年達到37億美元。

臨床疾病的準確、快速診斷和治療對於最佳臨床結果至關重要。由於其顯著的生物催化特性，酶被用於診斷多種疾病。

酵素生物感測器的發展增加了酵素在臨床診斷中的效用。儘管在臨床診斷方面有需求，但生物感測器的商業化和從研究到臨床的轉化仍然很低。然而，隨著研究和開發工作的不斷增加，乳酸、膽固醇和葡萄糖生物感測器正在商業化用於診斷用途。

蛋白酶是重要的訊號蛋白，對於多種病理過程至關重要，包括癌症、神經系統疾病、發炎疾病和心血管疾病。預計聚合酶和轉錄酶在預測期內將表現出最快的複合年成長率。此外，大量提供這些酶的參與者的存在預計將推動成長。 Kaneka Eurogentec SA、Toyobo Co., Ltd. 和 Sekisui Diagnostics, LLC 等主要企業生產和銷售各種聚合酶，包括 KOD DNA 聚合酶、Taq DNA 聚合酶、Tth DNA 聚合酶和 TTx DNA 聚合酶。

2019年，感染疾病領域佔據市場主導地位。全球範圍內 COVID-19 病例的快速增加正在推動診斷酶用於 COVID-19 診斷的採用率。基於即時 PCR、LAMP-PCR（環介導等溫擴增 -PCR）、多重 PCR 和數位 PCR 技術的定性和定量分子檢測在感染疾病診斷中的應用不斷增加，導致酶的可用性不斷提高這個細分市場正在推動需求。

酵素免疫組織化學 (IHC) 因其更好的對比度以及與用於檢測目標成分的多種染色技術的兼容性而成為組織學的首選。體外診斷 (IVD) 酵素可用於多種最終應用，用於分析組織檢體和體液。體外診斷 (IVD) 酶被廣泛的最終用戶使用，包括每天執行多次分析的大型實驗室和執行少量測試的小型診所。

2019 年，北美成為一個重要的區域市場。癌症患者數量的增加以及採用酵素對切片檢查樣本進行組織病理學檢查是預計推動該地區市場成長的其他一些因素。據預測，更大的目標人口、改善的醫療基礎設施、未滿足的臨床需求、政府舉措的增加以及先進診斷技術舉措活動的增加將推動亞太市場以最快的速度成長。

市場上的主要企業正在參與新產品發布、收購、聯盟、合作夥伴關係和地理擴張，以提高其在市場中的影響力。例如，2020年6月，Codexis, Inc.與Alphazyme LLC簽訂了合作協議，生產和聯合行銷高保真DNA聚合酶、T7 RNA聚合酶和逆轉錄酶。

IVD（體外診斷）酵素市場報告亮點

  • 按酶類型分類，聚合酶和轉錄酶由於在分子診斷檢測中的廣泛應用，在 2022 年佔據最大佔有率。
  • 按疾病類型分類，預計感染疾病領域將在整個預測期主導市場。
  • 按技術類型分類，由於組織學檢測在癌症診斷中的效用以及各種癌症類型盛行率的上升，到 2022 年，組織學檢測細分市場將佔據最大佔有率。
  • 從最終用途來看，醫院和診斷實驗室將在 2022 年佔據市場主導地位。由於住院患者的增加和癌症患者入院人數的增加，用於組織病理學和細胞病理學的切片檢查檢體大量湧入這些設施。
  • 由於該地區存在大量參與者，例如 Innovative Research、Bio-Rad Laboratories, Inc.、Rockland Nutrition, Inc.、MyBioSource.com、RayBiotech, Inc.，北美將在 2022 年主導整個市場。 。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 IVD（體外診斷）酵素市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • IVD（體外診斷）酵素市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 IVD（體外診斷）酵素：產品評估與趨勢分析

  • IVD（體外診斷）酵素市場：重點
  • IVD（體外診斷）酵素市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 蛋白酶
  • 聚合酶和轉錄酶
  • 核糖核酸酶
  • 其他

第5章 IVD（體外診斷）酵素：疾病類型的估計和趨勢分析

  • IVD（體外診斷）酵素市場：重點
  • IVD（體外診斷）酵素市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 感染疾病
  • 糖尿病
  • 腫瘤學
  • 心臟病學
  • 腎臟病學
  • 自體免疫疾病
  • 其他

第6章 IVD（體外診斷）酵素：技術評估與趨勢分析

  • IVD（體外診斷）酵素市場：重點
  • IVD（體外診斷）酵素市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 組織學檢測
  • 分子診斷
  • 臨床化學

第 7 章 IVD（體外診斷）用酵素：最終用途的估計與趨勢分析

  • IVD（體外診斷）酵素市場：重點
  • IVD（體外診斷）酵素市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 製藥和生物技術
  • 醫院和診斷實驗室
  • 學術實驗室

第8章 IVD（體外診斷）酵素市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的 IVD（體外診斷）酵素市場：主要市場點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Merck KGaA
    • Codexis, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Amano Enzymes Inc.
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Amicogen
    • Dyadic International
    • BBI Solutions
    • Affymetrix
    • American Laboratories
Product Code: GVR-4-68039-246-6

In-vitro Diagnostics Enzymes Market Growth & Trends:

The global in-vitro diagnostics enzymes market size is expected to reach USD 3.70 billion by 2030, expanding at a CAGR of 7.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Accurate and rapid diagnosis and treatment of clinical disorders are essential for optimal clinical outcomes. Owing to the noteworthy biocatalytic properties, enzymes are used in the diagnosis of a wide range of diseases.

The development of enzyme biosensors has increased the enzyme utility in clinical diagnostics. Despite the necessity in clinical diagnosis, the commercialization and translation of biosensors from research to clinics are still low. However, with an increase in R&D efforts, lactate, cholesterol, and glucose biosensors have been commercialized for diagnostic use.

Proteases are important signaling proteins that are critical to a few pathological processes, including cancer, neurological, inflammatory, and cardiovascular disorders. Polymerase and transcriptase enzymes are expected to exhibit the fastest CAGR over the forecast period. In addition, the presence of a substantial number of players that offer these enzymes is expected to enhance the growth. Key players such as Kaneka Eurogentec S.A.; Toyobo Co., Ltd.; and Sekisui Diagnostics, LLC manufacture and distribute a wide range of polymerases, including KOD DNA Polymerase, Taq DNA Polymerase, Tth DNA Polymerase, and TTx DNA Polymerase.

The infectious disease segment dominated the market in 2019. An exponential rise in the COVID-19 cases globally drives the adoption rate of diagnostic enzymes for COVID-19 diagnosis. An increase in the availability of qualitative and quantitative molecular assays based on real-time PCR, Loop-mediated Isothermal Amplification- PCR (LAMP-PCR), multiplex PCR, and digital PCR technologies for the diagnosis of infectious diseases drives the demand for enzymes in this segment.

Enzymatic immunohistochemistry (IHC) is preferred for histology owing to a better contrast ratio and the method's compatibility for use with multiple stains for the detection of target components. IVD enzymes are employed in different end-use settings for the analysis of tissue specimens and bodily fluids. A wide range of end users including large laboratories that conduct multiple analyses in a day and smaller clinics that conduct a few tests use enzymes for in-vitro diagnostics (IVD).

North America emerged as a prominent regional market in 2019. A rise in the number of cancer cases and the adoption of enzymes for histopathology of biopsy samples are some of the other factors expected to propel market growth in the region. The presence of a large target population, improvements in healthcare infrastructure, high unmet clinical needs, increase in government initiatives, and rise in R&D activities for advanced diagnostic techniques are anticipated to drive the Asia Pacific market with the fastest growth rate.

The key players in the market are involved in novel product launches, acquisitions, collaborations, partnerships, and geographical expansions to reinforce their market presence. For instance, in June 2020, Codexis, Inc. signed a collaboration agreement with Alphazyme LLC for the manufacture and co-marketing of high-fidelity DNA polymerase, T7 RNA polymerase, and reverse transcriptase.

In-vitro Diagnostics Enzymes Market Report Highlights:

  • By enzyme type, polymerase and transcriptase enzymes held the largest share in 2022 owing to their wide applications in molecular diagnostic assays
  • Based on disease type, the infectious disease segment is expected to dominate the market throughout the forecast period
  • In terms of technology type, the histology assays segment held the largest share in 2022 owing to the utility of histology assays in cancer diagnostics, coupled with a rising incidence of different cancer types
  • By end use, hospital and diagnostic labs dominated the market in 2022. They witness a high inflow of biopsy specimens for histopathology and cytopathology because of an increase in hospitalization and rise in the number of hospital admissions for cancer patients
  • North America dominated the overall market in 2022 owing to the presence of a substantial number of players in this region including Innovative Research; Bio-Rad Laboratories, Inc.; Rockland Immunochemicals, Inc.; MyBioSource.com; and RayBiotech, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Enzyme Type
    • 1.1.2. Disease Type
    • 1.1.3. Technology Type
    • 1.1.4. End use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Enzyme type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Technology type outlook
    • 2.2.4. End use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis

  • 4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Proteases
    • 4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Polymerase & Transcriptase
    • 4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Ribonuclease
    • 4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis

  • 5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious Disease
    • 5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.1. COVID -19 Testing
      • 5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.2. Hepatitis
      • 5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.3. HIV
      • 5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Diabetes
    • 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cardiology
    • 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Nephrology
    • 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis

  • 6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Histology Assays
    • 6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1. PCR Assays
      • 6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.2. NGS Assays
      • 6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.3. Others
      • 6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis

  • 7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Pharma & Biotech
    • 7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Hospital & Diagnostic Labs
    • 7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Academic Labs
    • 7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. U.K.
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Merck KGaA
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Codexis, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. F. Hoffmann-La Roche Ltd.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Amano Enzymes Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Advanced Enzymes Technologies Ltd.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Biocatalysts Ltd.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Amicogen
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Dyadic International
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. BBI Solutions
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Affymetrix
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. American Laboratories
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 3 North America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 North America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 5 North America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 8 U.S. in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 U.S. in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 10 U.S. in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 12 Canada in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Canada in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 14 Canada in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 16 Europe in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Europe in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 18 Europe in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 21 Germany in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Germany in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 23 Germany in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 25 UK in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 26 UK in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 27 UK in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 29 France in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 France in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 31 France in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 33 Italy in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Italy in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 35 Italy in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 37 Spain in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 38 Spain in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 39 Spain in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Sweden in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 41 Sweden in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 42 Sweden in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 43 Sweden in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 45 Norway in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 46 Norway in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 47 Norway in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 49 Denmark in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 50 Denmark in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 51 Denmark in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57 China in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 58 China in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 China in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 60 China in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 62 Japan in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 63 Japan in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 64 Japan in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 66 India in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 67 India in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 68 India in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Australia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 70 Australia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 71 Australia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 72 Australia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Thailand in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 74 Thailand in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 75 Thailand in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 76 Thailand in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 78 South Korea in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 79 South Korea in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 80 South Korea in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 82 Latin America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 83 Latin America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 84 Latin America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 87 Brazil in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Brazil in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 89 Brazil in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 91 Mexico in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 92 Mexico in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 93 Mexico in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 95 Argentina in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 96 Argentina in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 97 Argentina in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 104 South Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 105 South Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 106 South Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 112 UAE in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 113 UAE in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 114 UAE in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 In-vitro diagnostics enzymes: Market outlook
  • Fig. 9 In-vitro diagnostics enzymes: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 In-vitro diagnostics enzymes market driver impact
  • Fig. 15 In-vitro diagnostics enzymes market restraint impact
  • Fig. 16 In-vitro diagnostics enzymes market strategic initiatives analysis
  • Fig. 17 In-vitro diagnostics enzymes market: Enzyme type movement analysis
  • Fig. 18 In-vitro diagnostics enzymes market: Enzyme type outlook and key takeaways
  • Fig. 19 Proteases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Polymerase & transcriptase market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Ribonuclease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 In-vitro diagnostics enzymes market: Disease type movement analysis
  • Fig. 24 In-vitro diagnostics enzymes market: Disease type outlook and key takeaways
  • Fig. 25 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiology market estimates and forecasts, 2018 - 2030
  • Fig. 29 Nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 In-vitro diagnostics enzymes market: Technology type movement analysis
  • Fig. 33 In-vitro diagnostics enzymes market: Technology type outlook and key takeaways
  • Fig. 34 Histology assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical chemistry market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 In-vitro diagnostics enzymes market: End use type movement analysis
  • Fig. 39 In-vitro diagnostics enzymes market: End use type outlook and key takeaways
  • Fig. 40 Pharma & biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Hospital & diagnostic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Contract Research Organizations (CROs) market estimates and forecasts, 2018 - 2030
  • Fig. 43 Academic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global in-vitro diagnostics enzymes market: Regional movement analysis
  • Fig. 45 Global in-vitro diagnostics enzymes market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)